SOLIQUA
SOLIQUA
Approved
DIN Number
02478293
Drug Class
Human
Market Date
Sep 12, 2018
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02478293
AIG Number0260350001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A10AE54 INSULIN GLARGINE AND LIXISENATIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
INSULIN GLARGINEActive
Strength: 100 UNIT / ML
Monograph: INSULIN GLARGINE
LIXISENATIDEActive
Strength: 33 MCG / ML
Monograph: LIXISENATIDE